Patents by Inventor Michael B. Montalto
Michael B. Montalto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6849268Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.Type: GrantFiled: August 12, 2003Date of Patent: February 1, 2005Assignee: Abbott LaboratoriesInventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
-
Publication number: 20040062820Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.Type: ApplicationFiled: August 12, 2003Publication date: April 1, 2004Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
-
Patent number: 6620427Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.Type: GrantFiled: June 8, 2001Date of Patent: September 16, 2003Assignee: Abbott LaboratoriesInventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
-
Publication number: 20030026860Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.Type: ApplicationFiled: June 8, 2001Publication date: February 6, 2003Inventors: John B. Lasekan, Marc L. Masor, Michael B. Montalto, John D. Benson
-
Publication number: 20030021868Abstract: The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.Type: ApplicationFiled: August 13, 2002Publication date: January 30, 2003Inventors: Bridget Barrett-Reis, Patricia A. Reynolds, MIchael B. Montalto, Deborah L. O'Connor
-
Patent number: 6472003Abstract: The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder and a carbohydrate component present in a quantity of from about 15 wt/wt % to about 75 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.Type: GrantFiled: July 20, 2001Date of Patent: October 29, 2002Assignee: Abbott LaboratoriesInventors: Bridget Barrett-Reis, Patricia A. Reynolds, Michael B. Montalto, Deborah L. O'Connor
-
Publication number: 20020031576Abstract: The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder and a carbohydrate component present in a quantity of from about 15 wt/wt % to about 75 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.Type: ApplicationFiled: July 20, 2001Publication date: March 14, 2002Inventors: Bridget Barrett-Reis, Patricia A. Reynolds, Michael B. Montalto, Deborah L. O'Connor
-
Patent number: 6306908Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain &ohgr;-6 and &ohgr;-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.Type: GrantFiled: May 12, 2000Date of Patent: October 23, 2001Assignee: Abbott LaboratoriesInventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato
-
Patent number: 6294206Abstract: The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder and a carbohydrate component present in a quantity of from about 15 wt/wt % to about 75 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.Type: GrantFiled: March 21, 2000Date of Patent: September 25, 2001Assignee: Abbott LaboratoriesInventors: Bridget Barrett-Reis, Patricia A. Reynolds, Michael B. Montalto, Deborah L. O'Connor
-
Patent number: 6080787Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide .omega.-6 and .omega.-3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain .omega.-6 and .omega.-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.Type: GrantFiled: October 3, 1997Date of Patent: June 27, 2000Assignee: Abbott LaboratoriesInventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato